MedPath

Early Reassessment of Intravenous Antiinfective Therapy Due to "Antiinfective Reminders" (AIR Study)

Not Applicable
Completed
Conditions
Infection as Complication of Medical Care
Interventions
Other: electronic reminders
Registration Number
NCT01499927
Lead Sponsor
University of Zurich
Brief Summary

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs and risk of complications. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Detailed Description

Switching from intravenous application of antiinfective agents to oral therapy is often performed late including high costs, risk of complications as well as higher workload on nursing. This study will investigate the impact of displayed reminders in the electronic patient chart after 60h of intravenous therapy with an antiinfective agent.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74766
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
electronic reminderselectronic remindersBehavioral: Early switching from intravenous to oral antiinfective agents due to electronic reminders
Primary Outcome Measures
NameTimeMethod
duration of intravenous antiinfective therapy until switching1 year
Secondary Outcome Measures
NameTimeMethod
requests for consultations1 year
costs (per year, per day and patient)1 year
defined daily doses (per 100 days)1 year
duration of hospitalization1 year
ratio of narrow to broad-spectrum antibiotics1 year

Trial Locations

Locations (1)

University Hospital Zurich, Center for Clinical Research

🇨🇭

Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath